Mixed options sentiment in Pfizer (PFE), with shares up 20c, or 0.88%, near $23.50. Options volume relatively light with 82k contracts traded and calls leading puts for a put/call ratio of 0.66, compared to a typical level near 0.69. Implied volatility (IV30) dropped 0.95 near 26.99,in the top quartile of the past year, suggesting an expected daily move of $0.40. Put-call skew steepened, indicating increased demand for downside protection.Looking ahead: Pfizer (PFE) will report earnings before the open on 2025-08-05.Option markets are pricing in a 50% probability of a move greater than 3.35% or $0.79.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer’s TALZENNA Study: A New Hope for Prostate Cancer Treatment?
- Pfizer’s Latest Clinical Study Update: Avelumab and Axitinib in Renal Cell Cancer
- Pfizer’s New Study on PF-07934040: A Potential Game-Changer in Cancer Treatment?
- Pfizer’s New Study on Abrocitinib: A Potential Breakthrough for Pediatric Eczema
- Pfizer’s Ngenla Study: A Closer Look at Long-Term Safety for GHD Treatment